Celgene Corp (CELG) 86.66 $CELG
'Fast Money' Recap: Apple and Microsoft Earnings in the Spotlight
at The Street - 49 mins ago
The trading panel discussed whether Apple's quarter was good enough, how PCs are benefiting Microsoft and whether it's time to start buying auto stocks.
Final Glance: Biotechnology companies
AP - Tue Jul 22, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Celgene Set to Possibly Pullback After Yesterday's Rally of 1.58%
Comtex SmarTrend(R) - Tue Jul 22, 4:16PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.87 to a high of $87.12. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $86.19 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 3:55PM CDT
Celgene Corporation (CELG) is set to report second quarter 2014 results on Jul 24 before market opens.
Midday Glance: Biotechnology companies
AP - Tue Jul 22, 12:57PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 12:50PM CDT
Biogen Idec Inc. (BIIB) is scheduled to report its second-quarter 2014 results before the opening bell on Jul 23.
Alexion, 3 Other Top Biotechs Reporting Earnings
at Investor's Business Daily - Tue Jul 22, 11:42AM CDT
The four highest-rated of the market's seven big-cap biotechs are set to report second-quarter earnings this week, each with its own unique storyline. Biogen Idec (BIIB), the subject of Tuesday's New America, will be first to report before the open...
Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 10:20AM CDT
Gilead Sciences (GILD) is set to report second quarter 2014 results on Jul 23 after the market closes.
Early Glance: Biotechnology companies
AP - Tue Jul 22, 10:16AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Buy 100 Stocks Loved by Insiders
Selena Maranjian, The Motley Fool - Motley Fool - Tue Jul 22, 9:40AM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to invest in companies where insiders have been snapping up shares but don't have the time to track them down, the Guggenheim Insider...
Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out
at Investor's Business Daily - Tue Jul 22, 9:32AM CDT
Stocks stepped higher in firm volume Tuesday on a generally positive swell of earnings and economic news. The Nasdaq jumped 0.9% in early trade, with biotechs Alexion Pharmaceuticals (ALXN), Celgene (CELG) and Biogen (BIIB) leading the Nasdaq 100....
IBD 50 Ends Week Lower But Skyworks Soars
at Investor's Business Daily - Mon Jul 21, 5:47PM CDT
The IBD 50 fell for a second straight week amid the market's recent turbulence as biotech stocks sold off. But many leading stocks continue to hold up well, and few have flashed sell signals. The index of top growth stocks fell 0.6% for the week,...
Biogen Shares Rebound As Street Has A Change Of Heart
at Investor's Business Daily - Mon Jul 21, 3:09PM CDT
Biogen Idec heads into its second-quarter earnings report on one of its best rolls in years, as the biotech continues to benefit from heavy demand for its drugs to treat multiple sclerosis, cancer and autoimmune diseases. The No. 3 biotech by market...
Yellen Hates Biotech Stocks! Should You?
Brian Orelli, The Motley Fool - Motley Fool - Mon Jul 21, 1:01PM CDT
Federal Reserve Chairwoman Janet Yellen thinks your small-cap biotech is overvalued. The Fed's Monetary Policy Report, released on July 15, had this to say: [V]aluation metrics in some sectors do appear substantially stretched -- particularly...
Facebook, Gilead Headline IBD 50's Top 5 Earnings
at Investor's Business Daily - Sat Jul 19, 7:02AM CDT
With earnings season in full force, investors should focus on the very best companies. The elite IBD 50 ranks top-rated growth stocks, factoring in strong relative price strength and top fundamentals. The IBD 50 has several companies reporting...
'Fast Money' Recap: Apple and Microsoft Earnings in the Spotlight
at The Street - 49 mins ago
The trading panel discussed whether Apple's quarter was good enough, how PCs are benefiting Microsoft and whether it's time to start buying auto stocks.
Final Glance: Biotechnology companies
AP - Tue Jul 22, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Celgene Set to Possibly Pullback After Yesterday's Rally of 1.58%
Comtex SmarTrend(R) - Tue Jul 22, 4:16PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.87 to a high of $87.12. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $86.19 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 3:55PM CDT
Celgene Corporation (CELG) is set to report second quarter 2014 results on Jul 24 before market opens.
Midday Glance: Biotechnology companies
AP - Tue Jul 22, 12:57PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 12:50PM CDT
Biogen Idec Inc. (BIIB) is scheduled to report its second-quarter 2014 results before the opening bell on Jul 23.
Alexion, 3 Other Top Biotechs Reporting Earnings
at Investor's Business Daily - Tue Jul 22, 11:42AM CDT
The four highest-rated of the market's seven big-cap biotechs are set to report second-quarter earnings this week, each with its own unique storyline. Biogen Idec (BIIB), the subject of Tuesday's New America, will be first to report before the open...
Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 10:20AM CDT
Gilead Sciences (GILD) is set to report second quarter 2014 results on Jul 23 after the market closes.
Early Glance: Biotechnology companies
AP - Tue Jul 22, 10:16AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Buy 100 Stocks Loved by Insiders
Selena Maranjian, The Motley Fool - Motley Fool - Tue Jul 22, 9:40AM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to invest in companies where insiders have been snapping up shares but don't have the time to track them down, the Guggenheim Insider...
Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out
at Investor's Business Daily - Tue Jul 22, 9:32AM CDT
Stocks stepped higher in firm volume Tuesday on a generally positive swell of earnings and economic news. The Nasdaq jumped 0.9% in early trade, with biotechs Alexion Pharmaceuticals (ALXN), Celgene (CELG) and Biogen (BIIB) leading the Nasdaq 100....
IBD 50 Ends Week Lower But Skyworks Soars
at Investor's Business Daily - Mon Jul 21, 5:47PM CDT
The IBD 50 fell for a second straight week amid the market's recent turbulence as biotech stocks sold off. But many leading stocks continue to hold up well, and few have flashed sell signals. The index of top growth stocks fell 0.6% for the week,...
Biogen Shares Rebound As Street Has A Change Of Heart
at Investor's Business Daily - Mon Jul 21, 3:09PM CDT
Biogen Idec heads into its second-quarter earnings report on one of its best rolls in years, as the biotech continues to benefit from heavy demand for its drugs to treat multiple sclerosis, cancer and autoimmune diseases. The No. 3 biotech by market...
Yellen Hates Biotech Stocks! Should You?
Brian Orelli, The Motley Fool - Motley Fool - Mon Jul 21, 1:01PM CDT
Federal Reserve Chairwoman Janet Yellen thinks your small-cap biotech is overvalued. The Fed's Monetary Policy Report, released on July 15, had this to say: [V]aluation metrics in some sectors do appear substantially stretched -- particularly...
Facebook, Gilead Headline IBD 50's Top 5 Earnings
at Investor's Business Daily - Sat Jul 19, 7:02AM CDT
With earnings season in full force, investors should focus on the very best companies. The elite IBD 50 ranks top-rated growth stocks, factoring in strong relative price strength and top fundamentals. The IBD 50 has several companies reporting...
